Quinine Market: By Dosage (200 mg, 300 mg, and Others), By Administration (Oral, Intramuscular, Intravenous, and Others), By Application (Anti-Malarial, Problematic Leg Cramps, and Anti-pyretic), By End User (Hospitals and Clinics, Research Organizations and Others) And By Geography (North America, Europe, Asia-Pacific, Middle East And Africa, and South America) and Forecast To 2030.

Quinine Market size was valued at USD 1,783.9 million in 2023 and is poised to grow at a CAGR of 6.1% from 2024 - 2030. Quinine is a medication that is derived from the bark of the cinchona tree. Primarily used to treat malaria and babesiosis, specifically caused by Plasmodium falciparum. It can also be used to treat other conditions like leg cramps. While synthetic antimalarial drugs have largely replaced quinine as the first-line treatment for malaria, quinine continues to play a significant role in malaria management, particularly in regions where drug resistance is prevalent. The FDA has only approved it for treating malaria, but doctors can legally prescribe it for any type of treatment they deem appropriate.

The global quinine market refers to the worldwide production and consumption of quinine. This market encompasses various activities related to the extraction, processing, distribution, and sale of quinine and quinine-based products. The primary driver is the demand for quinine in the pharmaceutical industry, especially for treating malaria in regions where the disease is prevalent. Moreover, it is used in photochemistry as a popular fluorescence standard, which can propel market growth. Quinine is used to flavor tonic water as well as bitter lemon drink mixers, which is projected to grow tremendously. It’s one of the main ingredients in some alcoholic beverages such as gin which will also act as a driving factor of the market. Restraints include side effects such as nausea and dizziness, availability of alternative antimalarial drugs, such as artemisinin-based combination therapies (ACTs), and supply chain disruptions because of the dependency on cinchona trees. However, many countries, including the UK have banned the use of Quinine sulphate to treat malaria, which may impede market growth. Increasing healthcare access in developing countries, the rising popularity of craft beverages and premium tonic waters, and sustainable and ethical sourcing of cinchona bark present growth opportunities for quinine-based antimalarial treatments.

Recent Development In The Global Quinine Market :

• In September 2023, the Acquisition of Cinchona Health Pharmaceuticals by Sanofi was completed to enhance Sanofi's portfolio of antimalarial drugs.